AMN Healthcare announced Q4 2021 results with revenue of $1.36 billion, a 116% increase over the prior year. GAAP EPS was $2.42, and adjusted EPS was $2.95. Demand for workforce staffing and technology solutions grew, and investments in digital platforms improved clinician and client experience.
Consolidated revenue for the quarter was $1.363 billion, a 116% increase over prior year.
Net income was $116 million, or $2.42 per diluted share, compared to $9 million, or $0.19 per diluted share, in the same quarter last year.
Adjusted diluted EPS was $2.95 compared with $1.00 in the year-ago quarter.
The Physician and Leadership Solutions segment reported revenue of $164 million, higher by 47% year over year.
AMN Healthcare projects revenue between $1.475-1.515 billion, gross margin of 31.2% - 31.7%, SG&A as percentage of revenue 15.9% - 16.4%, operating margin 12.9% - 13.4%, and adjusted EBITDA margin 16.0% - 16.5% for Q1 2022.
Visualization of income flow from segment revenue to net income